Samsara BioCapital’s PepGen PEPG Stock Holding History

Samsara BioCapital’s Portfolio PEPG Stock Details PEPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-436,813	Closed	-$2.97M	–	40
2023 Q4	$2.97M	Sell	436,813 -214,237	-33%	-$1.17M	0.46%	26
2023 Q3	$3.31M	Hold	651,050	–	–	1.01%	27
2023 Q2	$5.82M	Hold	651,050	–	–	1.02%	19
2023 Q1	$7.96M	Hold	651,050	–	–	1.65%	14
2022 Q4	$8.7M	Hold	651,050	–	–	1.87%	15
2022 Q3	$5.91M	Hold	651,050	–	–	1.38%	19
2022 Q2	$6.46M	Buy	+651,050	New	+$7.26M	1.72%	16

Other funds holding PEPG

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Samsara BioCapital's PEPG Position: Q1 2024 in Review

Samsara BioCapital sold out of PepGen (PEPG) in Q1 2024, closing a stake of 436,813 shares — an estimated $2.97M sold.

Samsara BioCapital first reported a position in PEPG in Q2 2022 and held it in 7 quarters. The position peaked at $8.7M in Q4 2022. 56 funds tracked by Wall St. Rank hold PEPG as of Q1 2024.

Samsara BioCapital reported no remaining PepGen position as of Q1 2024 after selling out during the quarter.
Samsara BioCapital sold 436,813 PepGen shares in Q1 2024, an estimated $2.97M.
Samsara BioCapital first reported a position in PepGen in Q2 2022 and held it in 7 quarters.
Samsara BioCapital's PepGen position peaked at $8.7M in Q4 2022.
56 funds tracked by Wall St. Rank held PepGen as of Q1 2024.

Based on Samsara BioCapital's 13F filing for Q1 2024, filed 15 May 2024.